A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations.
Article Details
- CitationCopy to clipboard
Zabetian CP, Samii A, Mosley AD, Roberts JW, Leis BC, Yearout D, Raskind WH, Griffith A
A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations.
Neurology. 2005 Sep 13;65(5):741-4.
- PubMed ID
- 16157909 [ View in PubMed]
- Abstract
Referral-based studies indicate that a mutation (G2019S) in exon 41 of the LRRK2 gene might be a common cause of Parkinson disease (PD). The authors sequenced leucine-rich repeat kinase 2 (LRRK2) exons 31, 35, and 41 in 371 consecutively recruited patients with PD and found mutations in six (1.6%) subjects, including two heterozygous for new putative pathogenic variants (R1441H, IVS31 + 3A-->G). These data confirm the important contribution of LRRK2 to PD susceptibility in a clinic-based population.